Discussion Papers


Book Description




Breast Cancer Quality of Care


Book Description

Despite significant advances that have been made in breast cancer diagnosis and treatment, a disproportionate burden of the disease continues to fall on women from minority groups. Studies suggest that differentials in the quality of breast cancer care in the treatment stage influence breast cancer disparities. Because treatment is defined by medical intervention, the health system plays a critical role in understanding breast cancer disparities and needs to be further examined. Moreover, studies examining such differentials have focused on aggregated racial data, which may be masking smaller ethnic groups that may be at higher risk. This dissertation attempts to clarify the health system contribution to breast cancer quality of care disparities and highlights the need to examine breast cancer quality of care disparities using disaggregated racial/ethnic data in order to help inform the design of more targeted quality improvement efforts. Paper #1 examines the relationship between designated specialty cancer centers and breast cancer quality of care. In cancer care delivery, there has been an emerging trend for cancer centers to obtain special designations from one or more of the following institutions: the National Cancer Institute (NCI), the National Comprehensive Cancer Network (NCCN), and the American College of Surgeon’ Commission on Cancer. These designations are markers for high quality cancer care, yet little is known about the actual effectiveness of the care they provide or the communities that they tend to serve. Paper #2 examines breast cancer quality of care differences between Asian women (aggregated and disaggregated) and non-Hispanic White women. Cancer disparities research often focus on examining communities in aggregate. Recently, more scholars are utilizing disaggregated ethnic data when assessing cancer disparities in order to acknowledge the diversity of these large communities. Little is known about breast cancer quality of care disparities among Asian American ethnic groups. Paper #3 examines the relative contribution of within hospital and between hospital effects on racial/ethnic disparities on the quality of breast cancer treatment. Existing literature posits that there are two mechanisms at the health systems level that contribute to disparities in the quality of care received by minority groups. Some studies suggest that disparities are due to minorities receiving differential treatment within the same institution as White patients, while others propose that minorities tend to receive care from lower quality health care settings. Studies to date have not examined the ways in which the health system may be contributing to breast cancer quality of care disparities. Data from the California Cancer Registry (CCR) was used for the analyses. The study population consisted of women ages 20 years or older and who have had a first invasive primary breast cancer diagnosis between 2011-2014. This dissertation contributes to the existing literature on breast cancer disparities by clarifying the mechanism of the health system contribution to breast cancer disparities and uncovering disparities in disaggregated ethnic groups. Findings from this dissertation will provide important information for the development of quality improvement efforts in cancer care delivery.







Enhancing Data Systems to Improve the Quality of Cancer Care


Book Description

One of the barriers to improving the quality of cancer care in the United States is the inadequacy of data systems. Out-of-date or incomplete information about the performance of doctors, hospitals, health plans, and public agencies makes it hard to gauge the quality of care. Augmenting today's data systems could start to fill the gap. This report examines the strengths and weaknesses of current systems and makes recommendations for enhancing data systems to improve the quality of cancer care. The board's recommendations fall into three key areas: Enhance key elements of the data system infrastructure (i.e., quality-of-care measures, cancer registries and databases, data collection technologies, and analytic capacity). Expand support for analyses of quality of cancer care using existing data systems. Monitor the effectiveness of data systems to promote quality improvement within health systems.







Measuring the Quality of Breast Cancer Care in Women


Book Description

This evidence report describes the results of a systematic review of the scientific-medical literature designed to survey the range of quality measures assessing the quality of breast cancer care in women, and to characterize specific parameters potentially affecting their suitability for wider use. Specific emphasis was placed on diagnosis, treatment (including supportive care), follow up, and the reporting/documentation of this care. The population of interest was female adults diagnosed with, or in treatment for, any histological type of adenocarcinoma of the breast, including both in situ and invasive cancer. In addition to informing the research community and the public on the availability and utility of quality measures of breast cancer care, it is anticipated that the findings of this report will be used to help define an agenda for future research. The quality of healthcare refers to “the degree to which healthcare services for individuals and populations increase the likelihood of desired health outcomes and are consistent with current professional knowledge.” It is estimated that more than one trillion dollars is spent annually on healthcare in the United States, yet there are few systematic and comprehensive data on how well this care is provided by practitioners, organizations, and systems. Various sources (e.g., healthcare professionals, hospitals, health plans) have provided some data on healthcare, including its quality. However, the absence of a coordinated national quality measurement and reporting system has meant that these data are likely too inconsistent and incomplete to permit derivation of a national overview of problems in healthcare quality that could potentially serve to inform the public about the quality of its healthcare choices. Other than skin cancer, breast cancer remains the most common cancer in women and the second leading cause of cancer-related death. In the United States, it is estimated that, in 2003, over 211,000 women will be diagnosed with breast cancer, and approximately 40,000 will die from the disease. Although much less common, breast cancer also occurs in men, accounting for less than 1% of all breast cancers (approximately 1600 cases in 2003). According to data compiled by the Surveillance, Epidemiology and End Results Program (SEER), 1 in 8 women will develop breast cancer during their lifetime, with the risk increasing with age. Although breast cancer occurs more often in white women than in black or Asian women, cancer survival rates have been estimated to be 15% lower in black women compared with white women. Recent statistics (1992 - 1996) indicate that breast cancer-related deaths are declining, with the largest decrease observed in younger women, both white and black. The decline in death rates is attributed to earlier detection and improved treatment. Currently, it is recommended that all women over the age of 40 receive regular mammograms (every 1 to 2 years). What follows is a brief overview of the range of breast cancer care, including some reference to available evidence.




California Cancer Registry Enhancement for Breast Cancer Research


Book Description

The purpose of this project was to enhance the value of the California Cancer Registry (CCR) as a research tool for clinicians and epidemiologists interested in conducting breast cancer research. The objectives of the project were to: (1) classify breast cancers according to the major staging schemes currently in use in the U.S.; (2) increase the amount of treatment data for breast cancer; and (3) link breast cancer case date with other data bases to improve survival information and collect co-morbidity and insurance status information. These objectives were accomplished and the CCR is now actively pursuing a broader scope of research than had been previously possible. However, breast cancer first course of treatment data was demonstrated to be under-reported, and follow-up to retrieve it was labor intensive and not universally successful. Studies with those data continue to be severely constrained.